Bioactive fatty acids and coronary heart disease. Mechanisms and clinical effects of dietary fatty acids by Strand, Elin
Bioactive fatty acids and
coronary heart disease






























SCIENTIFIC ENVIRONMENT......................................................................................................... 2 
ACKNOWLEDGEMENTS ................................................................................................................. 3 
ABSTRACT .......................................................................................................................................... 5 
ABBREVIATIONS .............................................................................................................................. 8 
LIST OF PUBLICATIONS ............................................................................................................... 11 
CONTENTS ........................................................................................................................................ 12 




1.3.1 Peroxisome proliferator activated receptors .............................................................. 19 
1.3.2 PPAR agonists ............................................................................................................ 21 
  
1.4.1 Fatty acid metabolism ................................................................................................ 24 
1.4.2 Triglycerides and cardiovascular disease .................................................................. 26 
1.4.3 Omega-3 fatty acids and cardiovascular disease ....................................................... 27 
1.4.4 Omega-3 fatty acids and diabetes mellitus ................................................................. 28 
2. AIMS OF STUDY .................................................................................................................... 30 
  
  
3. SUBJECTS AND METHODS ................................................................................................ 31 
  
3.1.1 Study population .........................................................................................................31 
3.1.2 Dietary assessment ......................................................................................................34 
3.1.3 Assessment of clinical data .........................................................................................35 
3.1.4 Assessment of laboratory data ....................................................................................35 
3.1.5 Endpoints and follow-up .............................................................................................36 
3.1.6 Statistical analyses ......................................................................................................37 
  
3.2.1 Study design and sampling..........................................................................................41 
3.2.2 Tissue analyses ............................................................................................................43 
3.2.3 Statistical analyses ......................................................................................................44 
  
3.3.1 Human studies .............................................................................................................45 
3.3.2 Animal study ...............................................................................................................48 




5. DISCUSSION ............................................................................................................................56 
  
  
5.2.1 Changes in fatty acid metabolism ...............................................................................60 
5.2.2 Diet-induced effects on fatty acid composition ...........................................................61 
5.2.3 Mechanisms in relation to dietary omega-3 effects in humans ...................................63 
6. CONCLUSIONS .......................................................................................................................67 
7. FUTURE PERSPECTIVES .................................................................................................... 68 
SOURCE OF DATA .......................................................................................................................... 71 
PUBLICATIONS ............................................................................................................................... 86 
1. Introduction
1.1 Coronary heart disease
1.2 Diabetes mellitus
1.3 Pathways affected by dietary fatty acids
Ras Src
Ras




1.3.1 Peroxisome proliferator activated receptors 

1.3.2 PPAR agonists 




Figure 2. Structure of tetradecylthioacetic acid (TTA).
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Figure 4. Flow of randomized patients from WECAC to study populations in Papers 1 and 2. 
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Table 1. Covariates included in the multivariate adjusted models in Cox regression analyses in 
Papers 1 or 2
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Table 2. Covariates assessed for use (but not included) in Cox regression analyses in Papers 1 
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Table 3. Animal study diets
Diet (% w/v)1 Low fat Control TTA FO TTA + FO
Figure 5. Sub-group analyses on heart tissue of male Wistar rats after dietary intervention 
with TTA and/or FO – Gastric heart study. 
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Table 4. Daily dietary intakes by quartiles
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Table 5. Hazard ratios (and 95% CIs)1 for coronary events by quartiles of n-3 long-chain 
polyunsaturated fatty acids (LCPUFAs) (%TE) and fish (g)















Table 6. Hazard ratios (and 95% CIs) for acute myocardial infarction (fatal and non-fatal) by 
tertiles of dietary n-3 LCPUFA (%TE)1
423 patients with 
HbA1c ≥6.5%2
740 patients with
diabetes or HbA1c ≥6.5%3




Table 7. Hazard ratios (and 95% CIs) for acute myocardial infarction (fatal and non-fatal) by 
tertiles of dietary n-3 LCPUFA (%TE)1
Diabetes (n=258)2 Diabetes (n=317)3
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